Dark Eye Circle Treatment Singapore: Treat the Cause, Not Just the Shadow
You may not be tired—your under-eyes may simply be telling the wrong story. Dark circles can be caused by pigment, visible vessels, thin translucent skin, tear-trough shadowing, loss of collagen, eye bags, fluid retention—or several of these at the same time. That is why treating every dark circle with the same filler, laser or cream often disappoints.
Aquila Medical Center · 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914.
AI-created illustrative visual. Treatment suitability and expected improvement require an in-person medical assessment.
What is the right treatment for dark eye circles?
The best dark eye circle treatment depends on the cause. Brown pigment, blue-purple vascular visibility, thin skin, tear-trough hollowing and eye-bag shadowing are different problems. In selected patients whose darkness is amplified by thin skin, reduced collagen support, fine creasing or mild hollowing, microspherical polydioxanone (PDO) collagen biostimulation may be considered. Pigment or prominent eye bags usually need a different or additional treatment.
Key takeaway: dark eye circles describe an appearance, not one diagnosis. Treating the dominant cause first is more useful than choosing a product before assessment.
What causes dark eye circles? The main patterns we assess
The lower eyelid is anatomically complex. A brown circle, a blue-purple circle and a shadow from a deep tear trough may look similar in a selfie, yet they do not respond to the same treatment. Published reviews classify periorbital darkness as pigmentary, vascular, structural and mixed, with other contributors including edema, dermatitis, allergy and ageing.
1. Pigmentary darkness
Brown or brown-grey darkness may come from increased melanin in the epidermis or dermis. Genetics, ultraviolet exposure, chronic rubbing, eczema, allergic contact dermatitis and post-inflammatory pigmentation can contribute. In Singapore’s high-UV environment, daily photoprotection matters because ongoing ultraviolet exposure can deepen pigment and make treatment gains harder to maintain.
When pigment is the dominant cause, an injectable collagen treatment alone is not a pigment-removal procedure. The plan may need topical therapy, pigment-directed laser treatment, light-based treatment or carefully selected peels, depending on skin type and medical assessment.
2. Vascular / translucent darkness
The skin below the eye is extremely thin. When the dermis becomes thinner with age or intrinsic collagen loss, underlying vessels and the orbicularis muscle can become more visible, producing a blue, violet or reddish tone. This may be more obvious in fair skin, but translucent vascular darkness can occur across skin types.
This is one reason a collagen-supporting strategy is conceptually different from simply adding bulk. The objective is to improve the quality and support of the tissue so that underlying structures are less visually dominant.
3. Tear-trough shadowing
A depression extending from the inner corner of the eye toward the cheek can create a shadow that looks dark even when the skin itself is not heavily pigmented. Age-related changes in bone, fat compartments, ligaments and soft-tissue support can deepen this transition.
In true structural hollowing, volume restoration may help. However, the correct material, injection plane and amount matter greatly because the lower eyelid has little room for error. Some patients are better suited to biostimulatory support; others may benefit from carefully selected filler, fat grafting or surgical assessment.
4. Eye bags and edema
Puffiness can cast a crescent-shaped shadow directly beneath the bulge. Fluid retention, allergies and lymphatic congestion can make the lower eyelid look heavier. In patients with prominent fat prolapse or significant lower-eyelid bags, adding volume beneath the eye can sometimes make the area look fuller rather than fresher.
When eye bags dominate, we may discuss whether a non-surgical plan is realistic or whether an eye-bag or lower-eyelid surgical assessment is more appropriate.
5. Skin laxity and fine creasing
Loss of collagen and elastin contributes to fine lines, crepiness and poor light reflection. Uneven texture creates small shadows and can exaggerate the appearance of darkness. This is where skin-quality treatment, rather than simple filling, becomes important.
Collagen biostimulation can be considered when thin, less resilient skin is an important part of the problem, provided the patient is medically suitable and expectations are realistic.
6. Mixed dark circles
Mixed cases are extremely common. A patient may have inherited pigmentation, thin skin, a visible venous network and a tear trough at the same time. Treating only one layer may improve the eye area but will not necessarily erase every component.
At Aquila Medical Center, the consultation therefore focuses on identifying what proportion is pigment, translucency, structure, puffiness and skin quality before recommending a staged treatment plan.
PDO collagen biostimulation for dark eye circles: what the ingredient does
Our featured injectable approach uses polydioxanone (PDO) in microspherical form. PDO is a synthetic biodegradable polymer with a long history in absorbable medical sutures. It is broken down through hydrolysis over time. In aesthetic biostimulation, the material is formulated as small microspheres so it can be delivered into tissue using an injectable technique rather than placed as a conventional thread.
The purpose is not simply to place a permanent “filling gel” under the eye. The treatment is used as a collagen biostimulator: the material creates a controlled tissue response around the microspheres, with the clinical aim of encouraging new collagen formation and improving tissue support as the material gradually degrades.
This makes the treatment particularly relevant when dark circles are being amplified by thin translucent skin, reduced dermal support, fine creasing or mild structural hollowing. It may also be considered when a patient wants gradual improvement rather than an immediately obvious gel-like filling effect.
PDO has established medical use as an absorbable polymer; the injectable microsphere formulation is used for collagen biostimulation.
The goal is improvement in skin quality and support over time rather than aggressive immediate over-correction.
Pigment, vessels, skin laxity and eye bags can be addressed separately when needed.
Illustrative visual of a collagen-focused under-eye consultation. PDO microsphere treatment is not suitable for every cause of dark circles.
What a collagen-focused treatment is trying to change
For the right patient, the goal is to improve the tissue that creates the dark-circle appearance—not merely to camouflage it with more volume.
Dermal support
When lower-eyelid skin is thin and collagen-poor, underlying vessels and muscle may be more visible. Collagen remodelling aims to improve the structural quality of the dermis so the area appears better supported.
Fine texture
Crepey texture scatters light unevenly and can make the under-eye appear darker. Improving skin support may soften fine textural irregularities, although it will not replace resurfacing when significant texture or laxity is present.
Subtle hollowing
Biostimulation may provide gradual tissue support in selected mild-to-moderate hollows. Very deep tear troughs or major mid-face volume loss may require a different strategy or combination treatment.
More natural transition
The desired endpoint is not a swollen or overfilled lower eyelid. The aesthetic aim is a smoother transition from lower eyelid to cheek while preserving normal facial movement and expression.
Identify pigment, vessels, shadow, edema and skin quality.
PDO microspheres are placed using a physician-selected technique.
Tissue response and collagen remodelling develop gradually.
Reassess residual pigment, hollowing or eye-bag components.
Why hyaluronic acid filler is not our default answer for every dark eye circle
HA filler is not “bad” and it is not useless. In fact, published evidence supports it for appropriately selected tear-trough deformity. The problem is assuming that every dark circle is a tear trough.
| Clinical issue | HA tear-trough filler | PDO microsphere collagen biostimulation | Other treatment may be needed |
|---|---|---|---|
| True structural hollow | Can be useful Provides immediate volume when anatomy and candidate selection are appropriate. | May help selected cases Aims for gradual support rather than immediate gel volume. | Mid-face support, fat grafting or surgery may be considered in selected patients. |
| Brown pigmentation | Does not remove pigment | Does not directly remove pigment | Sun protection, topical therapy, pigment laser/light or peel may be more relevant. |
| Blue / vascular translucency | May alter contour but does not specifically treat visible vessels. | May be considered when thin skin and low dermal support contribute to translucency. | Vascular-directed treatment may be appropriate in selected cases. |
| Thin crepey skin | Volume does not necessarily improve dermal quality and superficial placement can be visible. | Collagen-focused Designed around tissue remodelling and support. | Skin boosters, energy devices or resurfacing may be considered depending on the problem. |
| Edema / malar bags | Candidate selection critical HA attracts water and swelling/edema is a recognised adverse event after tear-trough treatment. | Still requires cautious assessment; no injectable should be used indiscriminately in an edematous lower eyelid. | Allergy management, edema assessment or surgical review may be more appropriate. |
1. HA treats volume—not every cause of darkness
A structural tear trough can cast a shadow. For that specific problem, HA can be effective in selected patients. But pigmentary dark circles, post-inflammatory hyperpigmentation and visible vascular darkness have different mechanisms. If a patient has little hollowing, adding volume may do very little for the colour itself.
2. The lower eyelid is unforgiving
Because the skin is thin, small contour irregularities can become visible. A 2023 systematic review and meta-analysis of 31 reports involving 2,556 participants found high satisfaction with HA tear-trough injection, but also documented swelling/edema, bruising, contour irregularity and Tyndall discoloration as recognised adverse events. This is why “filler for everyone” is not a medically sensible approach.
3. Fluid-prone patients need extra caution
Some people already have lower-eyelid edema, malar mounds, allergies or impaired lymphatic drainage. In those patients, a hydrophilic gel can be problematic. Assessment should include puffiness at rest, morning swelling, allergy history, previous filler and whether the darkness improves or worsens when the tissue is gently stretched.
4. We still use the right tool for the right anatomy
This page should not be interpreted as a claim that HA filler has no role under the eye. If the dominant problem is a clean, well-defined structural hollow with good skin quality and minimal edema, a physician may still discuss under-eye filler. The point is that dark circles deserve diagnosis before product selection.
Good treatment begins with good candidate selection
A collagen biostimulator may be considered when the dark-circle appearance is driven substantially by thin skin, reduced dermal support, fine creasing or mild structural hollowing.
Especially when visible underlying structures contribute to a blue-purple appearance.
When tissue quality rather than bulk is the main concern.
Where gradual tissue support may provide a natural transition.
Provided their anatomy and expectations are suitable for an injectable treatment.
When this may not be the main treatment
Collagen biostimulation is not a universal solution. If your dark circles are predominantly brown pigmentation, pigment-directed treatment may have a larger role. If there is significant prolapsed lower-eyelid fat, a surgical consultation may be more appropriate. If there is substantial mid-face volume loss, correction of the cheek-lid transition may be necessary. If active dermatitis or severe allergy is present, the inflammatory trigger should be treated first.
Injectable treatment may also need to be postponed or avoided in patients with active infection at the treatment site, certain medical conditions, pregnancy or breastfeeding, bleeding-risk issues, or a history that makes the treatment unsuitable. Your doctor will review relevant medical history, medicines and previous procedures before proceeding.
What happens at Aquila Medical Center
The under-eye is a high-detail area. The consultation is therefore as important as the injection itself.
Clinical assessment
We assess the colour of the dark circle, the depth of the tear trough, skin thickness, visible vessels, eye bags, edema, cheek support, skin laxity and whether the darkness changes when the skin is stretched or the lighting angle changes. We also ask about allergies, eczema, rubbing, sleep, previous filler and previous laser treatment.
Personalised treatment mapping
If microspherical PDO is suitable, the physician plans where tissue support is needed and where treatment should be avoided. The lower eyelid is not treated as a flat canvas. Anatomy, orbital rim position, tear-trough ligament, fat pads, vascular structures and cheek-lid transition all influence the plan.
Preparation and procedure
The area is cleansed and comfort measures are used as appropriate. Depending on anatomy and physician preference, a needle or blunt cannula technique may be selected. The objective is controlled placement rather than aggressive filling. Procedure time varies according to whether the under-eye is treated alone or as part of a broader plan.
Early recovery
Temporary swelling, tenderness, redness or bruising can occur after injectable treatment. The degree and duration vary between patients. Because the lower eyelid shows swelling easily, it is sensible to avoid scheduling treatment immediately before an important event. You will receive aftercare instructions based on the procedure performed.
Gradual collagen remodelling
A collagen biostimulator is not judged only by how the area looks immediately after injection. Tissue remodelling develops over time. Follow-up allows us to assess whether skin quality and support are improving and whether any residual pigment, vascular component or structural hollow needs a different modality.
Maintenance based on biology—not a fixed package
There is no single treatment interval that is right for everyone. Age, baseline collagen, anatomy, lifestyle, ultraviolet exposure, smoking, previous aesthetic procedures and the severity of the problem all influence the plan. We favour reassessment over automatically repeating treatment on a rigid schedule.
Sometimes the best dark-circle plan uses more than one tool
Because dark circles are frequently mixed, the best result may come from treating different causes separately rather than trying to force one procedure to do everything.
Pigment-directed treatment
If melanin is a major component, we may discuss a pigment-focused programme and strict sun protection. Aquila Medical Center offers doctor-led pigmentation treatment in Singapore, where laser, light, topical therapy or peels can be selected according to diagnosis and skin type.
Skin-quality treatment
Hydration, barrier health and texture may also influence how light reflects from the lower eyelid. Selected patients may benefit from a skin booster or another regenerative skin-quality treatment. These treatments have different functions from a collagen biostimulator and should not be presented as interchangeable.
Structural assessment
If the main problem is a pronounced tear trough or cheek-lid hollow, an under-eye filler assessment or broader facial contouring consultation may be more relevant. If lower-eyelid fat prolapse is significant, read about eye-bag correction and discuss whether surgery should be considered.
Why combination planning matters
A patient with brown pigment plus a tear trough may need both pigment treatment and structural support. A patient with a blue-purple hue plus thin skin may need a different plan. The word “dark circle” describes an appearance—not a single disease process.
Natural improvement is the goal—not an overfilled lower eyelid
Under-eye rejuvenation is successful when you look more rested without looking as though the area has been obviously augmented.
What may improve
Depending on the cause and treatment plan, patients may notice a smoother lower-eyelid-to-cheek transition, better skin support, less visibility of underlying structures, softer fine creasing and a reduction in shadowing. If pigmentation is treated separately, the overall brightness can improve further.
What may remain
Genetic pigment, prominent veins, severe eye bags, deep skeletal hollowing or significant skin laxity may not disappear with a single injectable treatment. It is better to identify these limits before treatment than to promise unrealistic “100% removal” of dark circles.
How long does it take?
Biostimulatory treatment is gradual. Early post-procedure appearance can be influenced by swelling, so the meaningful assessment is not the mirror immediately after injection. Collagen remodelling evolves over weeks to months, and follow-up timing is individualised.
What you should know before injectable under-eye treatment
Common short-term effects
As with other injectable procedures, temporary swelling, redness, tenderness, bruising or small areas of firmness can occur. The lower eyelid can exaggerate even mild swelling because the tissue is delicate. Plan treatment with enough time before photographs, travel, weddings or important work events.
Less common but important complications
Any injectable procedure can have complications. These may include infection, persistent swelling, asymmetry, palpable or visible nodules, prolonged inflammation, contour irregularity and unsatisfactory aesthetic outcome. Vascular complications are a serious risk with facial injections and require appropriate medical training, anatomical knowledge and urgent management if suspected.
Why physician assessment matters
The under-eye contains delicate vessels and sits adjacent to the orbit. Treatment choice, depth, volume, cannula or needle selection and injection pattern should be based on anatomy rather than a standard package. Previous filler can also change tissue behaviour; tell us if you have had under-eye filler even if it was years ago.
Aftercare principles
Your doctor will provide procedure-specific advice. In general, patients are often asked to avoid unnecessary pressure or massage unless instructed, avoid strenuous exercise and excessive heat for a short period, and keep the injection site clean. If you develop severe pain, unusual skin colour change, rapidly increasing swelling, visual disturbance, fever or other concerning symptoms, seek urgent medical review.
What home care can—and cannot—do for dark eye circles
Sleep deprivation does not create every dark circle, but fatigue can make existing darkness look worse. Allergies may promote rubbing and congestion. Ultraviolet exposure can worsen pigment. Dehydration can temporarily make the face look less plump. Good home care therefore supports treatment, even when it cannot correct anatomy.
Useful daily habits
Use broad-spectrum sun protection around the eye area, wear sunglasses outdoors, avoid chronic rubbing, manage eczema or allergies appropriately, maintain regular sleep where possible, and use gentle skincare rather than aggressive scrubs or acids close to the eyelids. If you use active skincare, introduce it carefully because irritation can worsen post-inflammatory pigmentation.
What eye creams cannot reliably correct
No eye cream can replace lost bone support, reposition prolapsed fat or completely eliminate a deep tear trough. Brightening ingredients may help pigment at the surface, and moisturising ingredients may temporarily improve fine dehydration lines, but a structural or vascular cause will usually require a different strategy.
When to seek medical evaluation rather than aesthetic treatment alone
Most dark circles are benign. However, a medical review is sensible if darkness is new, markedly one-sided, associated with significant swelling, rash, eye irritation, pain, visual symptoms, systemic symptoms or a major change in general health. Persistent dermatitis, uncontrolled allergy, sleep problems and nutritional or medical concerns may need separate assessment before cosmetic treatment is considered.
Singapore-specific practical point
Singapore’s ultraviolet exposure is significant year-round. If pigment is part of your dark-circle pattern, consistent daily photoprotection is not optional “extra skincare”; it is part of protecting your treatment result. Sunscreen should be used carefully around the eyes to avoid irritation, and sunglasses provide additional physical protection.
Dark eye circle treatment in Singapore CBD
Aquila Medical Center is located at 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914, in Singapore’s Central Business District. SBF Center is close to Tanjong Pagar MRT and Telok Ayer MRT, providing convenient access for patients visiting from the downtown area.
For Singapore patients, assessment should also consider local factors such as year-round ultraviolet exposure and a tendency toward post-inflammatory pigmentation in susceptible skin types. These can influence both the cause of under-eye darkness and how a treatment plan is maintained over time.
To ask whether microspherical PDO collagen biostimulation is suitable for your under-eye concern, WhatsApp +65 8755 5696. Treatment suitability can only be confirmed after a medical assessment.
At a glance
Clinic: Aquila Medical Center
Location: 160 Robinson Road, #05-01 SBF Centre Medical Suites, Singapore 068914
Area: Singapore CBD
Nearby MRT: Tanjong Pagar and Telok Ayer
WhatsApp: +65 8755 5696
Appointments and treatment plans are individualised after physician assessment.
Relevant Aquila Medical Center pages
Dark circles overlap with pigmentation, skin quality, tear-trough contour and lower-eyelid anatomy. These internal resources explain the other treatment pathways that may be discussed during consultation.
Dark eye circle treatment FAQ
What is the best treatment for dark eye circles in Singapore?
What ingredient is used in the featured collagen treatment?
Is this the same as a PDO thread lift?
Can PDO collagen biostimulation remove brown pigmentation?
Why not simply use hyaluronic acid filler under the eyes?
Will the treatment make my under-eyes look puffy?
How quickly will I see a result?
How many sessions will I need?
Can I combine this with laser treatment?
What if my dark circles are caused by eye bags?
Does lack of sleep cause dark eye circles?
Where is Aquila Medical Center located?
What is actually making your under-eyes look dark?
If you have tried eye creams, concealer, sleep, facials or previous filler and the darkness keeps returning, the next step is not automatically “more product”. It is a proper assessment of pigment, vessels, skin thickness, hollowing and eye-bag anatomy.
At Aquila Medical Center in Singapore, we can assess whether a microspherical PDO collagen biostimulator is appropriate for your under-eye pattern and whether another treatment should be combined or chosen instead.
References & evidence notes
This page is educational and does not replace an in-person medical assessment. Dark-circle treatment literature is heterogeneous, and product-specific evidence for injectable PDO microspheres is still developing. Claims on this page are intentionally framed around mechanism, candidate selection and established dark-circle classifications rather than guaranteeing a specific outcome.
- Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S, Bansal S. Periorbital Hyperpigmentation: A Comprehensive Review. J Clin Aesthet Dermatol. 2016. PubMed PMID: 26962392. PubMed
- Roberts WE. Periorbital hyperpigmentation: review of etiology, medical evaluation, and aesthetic treatment. J Drugs Dermatol. 2014;13(4):472-482. PubMed PMID: 24719068. PubMed
- Friedmann DP, Goldman MP. et al. Treatments of Periorbital Hyperpigmentation: A Systematic Review. Dermatol Surg. 2021;47(1):70-74. PubMed PMID: 32740208. PubMed
- Wang et al. The Efficacy and Safety of Hyaluronic Acid Injection in Tear Trough Deformity: A Systematic Review and Meta-analysis. Aesthetic Plast Surg. 2023. PubMed PMID: 37684413. PubMed
- Ray JA, Doddi N, Regula D, Williams JA, Melveger A. Polydioxanone (PDS), a novel monofilament synthetic absorbable suture. Surg Gynecol Obstet. 1981;153(4):497-507. PubMed PMID: 6792722. PubMed
- Martins JA, Lach AA, Morris HL, Carr AJ, Mouthuy PA. Polydioxanone implants: a systematic review on safety and performance in patients. J Biomater Appl. 2020. PMC
- Amin M, Mercado V, Velazco G, Corvalan V, Kwon HJ. Regenerative Synergy in Facial Rejuvenation: A Pilot Clinical Study of Polydioxanone Microspheres, Organic Silicon, and Adipostructuring. Cureus. 2026;18(3):e104912. This was a small multimodal facial-rejuvenation study and should not be interpreted as definitive evidence for isolated under-eye dark-circle treatment. PubMed
Medical advertising note: treatment suitability, expected improvement, number of sessions, risks and alternatives should be confirmed during medical consultation. The commercial product brand is intentionally not used in the patient-facing copy.